Eicosapentaenoic Acid

"Eicosapentaenoic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families.

Descriptor ID	D015118
MeSH Number(s)	D10.212.302.380.410.385 D10.251.355.255.200 D10.251.355.337.290 D10.627.430.450.390
Concept/Terms	Eicosapentaenoic Acid Eicosapentaenoic Acid Eicosapentanoic Acid Acid, Eicosapentanoic omega-3-Eicosapentaenoic Acid omega 3 Eicosapentaenoic Acid Timnodonic Acid 5,8,11,14,17-Eicosapentaenoic Acid 5,8,11,14,17-Icosapentaenoic Acid

Below are MeSH descriptors whose meaning is more general than "Eicosapentaenoic Acid".

Chemicals and Drugs [D]
Lipids [D10]
Fats [D10.212]
Dietary Fats [D10.212.302]
Dietary Fats, Unsaturated [D10.212.302.380]
Fatty Acids, Omega-3 [D10.212.302.380.410]
Eicosapentaenoic Acid [D10.212.302.380.410.385]
Fatty Acids [D10.251]
Fatty Acids, Unsaturated [D10.251.355]
Eicosanoids [D10.251.355.255]
Eicosapentaenoic Acid [D10.251.355.255.200]
Fatty Acids, Omega-3 [D10.251.355.337]
Eicosapentaenoic Acid [D10.251.355.337.290]
Oils [D10.627]
Fish Oils [D10.627.430]
Fatty Acids, Omega-3 [D10.627.430.450]
Eicosapentaenoic Acid [D10.627.430.450.390]

Below are MeSH descriptors whose meaning is related to "Eicosapentaenoic Acid".

Below are MeSH descriptors whose meaning is more specific than "Eicosapentaenoic Acid".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Eicosapentaenoic Acid" by people in this website by year, and whether "Eicosapentaenoic Acid" was a major or minor topic of these publications.

Bar chart showing 8 publications over 5 distinct years, with a maximum of 2 publications in 2013 and 2019 and 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2009	1	0	1
2013	1	1	2
2019	2	0	2
2022	1	0	1
2023	0	2	2

Below are the most recent publications written about "Eicosapentaenoic Acid" by people in Profiles.

Weintraub WS, Bhatt DL, Zhang Z, Dolman S, Boden WE, Bress AP, Bellows BK, Derington CG, Philip S, Steg G, Miller M, Brinton EA, Jacobson TA, Tardif JC, Ballantyne CM, Kolm P. Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States. J Am Heart Assoc. 2024 01 02; 13(1):e032413.

View in: PubMed
Olshansky B, Bhatt DL, Miller M, Steg PG, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT, Juliano RA, Jiao L, Kowey PR, Reiffel JA, Tardif JC, Ballantyne CM, Chung MK. Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT. J Am Heart Assoc. 2023 03 07; 12(5):e026756.

View in: PubMed
Weintraub WS, Bhatt DL, Zhang Z, Dolman S, Boden WE, Bress AP, King JB, Bellows BK, Tajeu GS, Derington CG, Johnson J, Andrade K, Steg PG, Miller M, Brinton EA, Jacobson TA, Tardif JC, Ballantyne CM, Kolm P. Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment. JAMA Netw Open. 2022 02 01; 5(2):e2148172.

View in: PubMed
Walker RE, Jackson KH, Tintle NL, Shearer GC, Bernasconi A, Masson S, Latini R, Heydari B, Kwong RY, Flock M, Kris-Etherton PM, Hedengran A, Carney RM, Skulas-Ray A, Gidding SS, Dewell A, Gardner CD, Grenon SM, Sarter B, Newman JW, Pedersen TL, Larson MK, Harris WS. Predicting the effects of supplemental EPA and DHA on the omega-3 index. Am J Clin Nutr. 2019 10 01; 110(4):1034-1040.

View in: PubMed
Setty BNY, Betal SG, Miller RE, Brown DS, Meier M, Cahill M, Lerner NB, Apollonsky N, Stuart MJ. Relationship of Omega-3 fatty acids DHA and EPA with the inflammatory biomarker hs-CRP in children with sickle cell anemia. Prostaglandins Leukot Essent Fatty Acids. 2019 07; 146:11-18.

View in: PubMed
Gerstenblith AT, Baskin DE, Shah CP, Wolfe JD, Fineman MS, Kaiser RS, Ho AC. Electroretinographic effects of omega-3 Fatty Acid supplementation on dry age-related macular degeneration. JAMA Ophthalmol. 2013 Mar; 131(3):365-9.

View in: PubMed
Jacobs BR, Nadkarni V, Goldstein B, Checchia P, Ayad O, Bean J, DeMichele S. Nutritional immunomodulation in critically ill children with acute lung injury: feasibility and impact on circulating biomarkers. Pediatr Crit Care Med. 2013 Jan; 14(1):e45-56.

View in: PubMed
Pratt CM, Reiffel JA, Ellenbogen KA, Naccarelli GV, Kowey PR. Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study. Am Heart J. 2009 Aug; 158(2):163-169.e1-3.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement